Form 4: CytoDyn Inc. (CYDY), Naydenov Jordan G, transaction 09/23/2021

Summary

A Form 4 filed with the Securities and Exchange Commission for Naydenov Jordan G, as printed, a director of CytoDyn Inc. (CYDY). It reports that on 09/23/2021 the reporting person exercised warrants (code M) for 888,888 shares of common stock at $0.45 and for 133,332 and 266,668 shares at $0.75, bringing direct ownership to 7,990,211 shares. The explanation says that on September 23, 2021, as an inducement to exercise, the issuer and the reporting person agreed to amend three warrants to purchase a total of 644,444 shares so that twice as many shares could be purchased for double the total original exercise price. Table II lists the original warrants as disposed of and the amended warrants as acquired. Michael D. Mulholland signed (/s/) as Attorney-in-fact on 09/27/2021.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * Naydenov Jordan G (Last) (First) (Middle) 1111 MAIN STREET, SUITE 660 (Street) VANCOUVER WA 98660 (City) (State) (Zip) | Naydenov Jordan G | (Last) | (First) | (Middle) | 1111 MAIN STREET, SUITE 660 | VANCOUVER | WA | 98660 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol CytoDyn Inc. [ CYDY ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below) | X | Director | 10% Owner | Officer (give title below) | Other (specify below)
3. Date of Earliest Transaction
 (Month/Day/Year) 09/23/2021
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 09/23/2021 | M | 888,888 | A | $ 0.45 | 7,590,211 | D
Common Stock | 09/23/2021 | M | 133,332 | A | $ 0.75 | 7,723,543 | D
Common Stock | 09/23/2021 | M | 266,668 | A | $ 0.75 | 7,990,211 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Warrant (Right to Buy) | $ 0.45 | 09/23/2021 | D | 444,444 | 12/13/2019 | 12/13/2024 | Common Stock | 444,444 | (1) | 0 | D
Warrant (Right to Buy) | $ 0.75 | 09/23/2021 | D | 66,666 | 07/26/2017 | 07/26/2022 | Common Stock | 66,666 | (1) | 0 | D
Warrant (Right to Buy) | $ 0.75 | 09/23/2021 | D | 133,334 | 01/31/2018 | 01/31/2023 | Common Stock | 133,334 | (1) | 0 | D
Warrant (Right to Buy) | $ 0.45 | 09/23/2021 | A | 888,888 | 09/23/2021 | 12/13/2024 | Common Stock | 888,888 | (1) | 888,888 | D
Warrant (Right to Buy) | $ 0.75 | 09/23/2021 | A | 133,332 | 09/23/2021 | 07/26/2022 | Common Stock | 133,332 | (1) | 133,332 | D
Warrant (Right to Buy) | $ 0.75 | 09/23/2021 | A | 266,668 | 09/23/2021 | 01/31/2023 | Common Stock | 266,668 | (1) | 266,668 | D
Warrant (Right to Buy) | $ 0.45 | 09/23/2021 | M | 888,888 | 09/23/2021 | 12/13/2024 | Common Stock | 888,888 | (1) | 0 | D
Warrant (Right to Buy) | $ 0.75 | 09/23/2021 | M | 133,332 | 09/23/2021 | 07/26/2022 | Common Stock | 133,332 | (1) | 0 | D
Warrant (Right to Buy) | $ 0.75 | 09/23/2021 | M | 266,668 | 09/23/2021 | 01/31/2023 | Common Stock | 266,668 | (1) | 0 | D
Explanation of Responses:
1. On September 23, 2021, as an inducement to exercise, the Issuer and the Reporting Person agreed to amend three warrants held by the Reporting Person (the "Warrants") to purchase a total of 644,444 shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock"), pursuant to which twice as many shares could be purchased for double the total original exercise price.
Remarks:
By: /s/ Michael D. Mulholland, Attorney-in-fact | 09/27/2021
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_CYDY_4_filed2021-09-27_0000899243-21-037904.xml

Size

25,488 bytes

SHA-256

c09ea633263f0b64cfd12d3ed06cdde830abadfe667ef87cbd83acf4305690b5

Our copy

SEC_CYDY_4_filed2021-09-27_0000899243-21-037904.xml

Original

www.sec.gov